Condensed Consolidated Statement of Shareholders Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Feb. 02, 2019	$ 130,800	$ 169,477	$ (38,677)
Balance, beginning of period (in shares) at Feb. 02, 2019		14,504,824
Increase (Decrease) in Stockholders Equity [Roll Forward]
Cumulative effect of change in accounting principle	(331)		(331)
Employee stock purchases (in shares)		6,880
Employee stock purchases	68	$ 68
Stock-based compensation expense	$ 560	$ 560
Repurchase and retirement of common stock (in shares)	287,056	287,056
Repurchase and retirement of common stock	$ 2,368		2,368
Net loss	(8,921)		(8,921)
Balance, end of period at May. 04, 2019	$ 119,808	$ 170,105	(50,297)
Balance, end of period (in shares) at May. 04, 2019	14,224,648	14,224,648
Balance, beginning of period at Feb. 01, 2020	$ 76,955	$ 172,885	(95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020	13,955,826	13,955,826
Increase (Decrease) in Stockholders Equity [Roll Forward]
Cumulative effect of change in accounting principle	$ 0
Employee stock purchases (in shares)		34,999
Employee stock purchases	35	$ 35
Restricted stock units vested		32,341
Net share settlement of restricted stock units, Shares		(8,663)
Net share settlement of restricted stock units	(8)	$ (8)
Stock-based compensation expense	$ 307	307
Repurchase and retirement of common stock (in shares)	0
Net loss	$ (7,438)		(7,438)
Balance, end of period at May. 02, 2020	$ 69,851	$ 173,219	$ (103,368)
Balance, end of period (in shares) at May. 02, 2020	14,014,503	14,014,503